Company intelligence / Profile preview

Opmed

Boston, Massachusetts, United Statesopmed.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Opmed’s platform uses advanced artificial intelligence and network science to optimize operating room scheduling and resource allocation in hospitals. The system analyzes billions of possible scenarios to generate optimal schedules that improve utilization rates, reduce costs, minimize staff overtime, and decrease patient wait times. Hospitals using the platform have reported significant financial savings—potentially over $1 million per OR annually—and improved patient care through faster access to procedures. The solution can be implemented within 2–4 weeks at new sites[4][5].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Geisinger Health System

Beyond the preview

Go deeper on Opmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opmed.

Explore the full profile